.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Cipla
Chinese Patent Office
Fuji
Teva
Merck
Harvard Business School
Chubb
QuintilesIMS
UBS

Generated: February 18, 2018

DrugPatentWatch Database Preview

Drug Master Files for: ethanolamine

« Back to Dashboard


DMF No. Status Type Submission Date Holder Subject
9192AII6/24/1991AVANTI POLAR LIPIDS INC1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE
11311IIV1/25/1995GENZYME PHARMACEUTICALS LLCN-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE SODIUM SALT (MPEG-DSPE)
11553III6/12/1995AVANTI POLAR LIPIDS INC1,2-DIPALMITOYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE-N-(POLYETHYLENE GLYCOL 5000)
13111III8/5/1998AVANTI POLAR LIPIDS INC1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE-N-GLUTARYL
14925III6/18/2000AVANTI POLAR LIPIDS INC1,2-DIPALMITOYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE(DPPE)
19731AIV8/31/2006NOF CORPN-(METHYLPOLYOXYETHYLENE OXYCARBONYL)-1, 2- DISTEAROYL--SN- GLYCERO-3- PHOSPHOETHANOLAMINE SODIUM SALT (DSPE-PEG2000)
20221AIV1/31/2007CORDEN PHARMA SWITZERLAND LLCN-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE SODIUM SALT (MPEG-2000-DSPE)
21802AII7/17/2008AVANTI POLAR LIPIDS INC1,2-DIPALMITOYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE-N-(BIOTINYL) (SODIUM SALT)(16:0 BIOTINYL PE)(770285)
25329AIV9/21/2011NIPPON FINE CHEMICAL CO LTDA LIPOSOMAL EXCIPIENT, N-(CARBONYL-METHOXYPOLYETHYLENEGLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE, SODIUM SALT (MPEG2000-DSPE)
28132AII3/24/2014CEDARBURG PHARMACEUTICALS INCBULK ETHANOLAMINE OLEATE API IN SOLUTION
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Healthtrust
McKesson
Daiichi Sankyo
Novartis
Chinese Patent Office
US Department of Justice
Teva
Cipla
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot